Navigation Links
Jessica Alba, Christina Applegate, Jennifer Connelly, Miley Cyrus & Jimmy Fallon on Board to Host Entertainment Industry Foundation's 2009 Revlon Run/Walk

Revlon Run/Walk New York to Take Place on May 2; Los Angeles to Follow on May 9

LOS ANGELES, April 2 /PRNewswire/ -- Revlon (NYSE: REV), Lilly Tartikoff, and the Entertainment Industry Foundation (EIF) announced that Revlon spokeswomen Jennifer Connelly and Jessica Alba along with NBC late night host Jimmy Fallon will host the 2009 EIF Revlon Run/Walk for Women in New York taking place on Saturday, May 2, 2009, while hosts Emmy-nominated star of ABC's "Samantha Who" Christina Applegate along with actress, singer and star of "Hannah Montana" Miley Cyrus, her mother Tish Cyrus, Revlon spokeswoman Beau Garrett and special guest and star of ABC's "Dancing with the Stars" Carrie Ann Inaba will join together at the Los Angeles event the following week on Saturday, May 9 during Mother's Day weekend. EIF's Revlon Run/Walk event is one of the nation's largest single-day fundraisers to support women's cancer research, counseling and outreach programs in New York City and Los Angeles.

The 12th annual New York race starts in Times Square and finishes in the East Meadow of Central Park and attracts nearly 40,000 participants. The 16th annual Los Angeles Race takes place at the Los Angeles Memorial Coliseum at Exposition Park and attracts close to 60,000 participants each year. The EIF Revlon Run/Walk For Women was launched in 1993 through the combined efforts of Lilly Tartikoff, Ronald O. Perelman, chairman of Revlon, Inc. and EIF. Since inception, nearly $55 million in grants have been made from the combined events in New York and Los Angeles.

"Hundreds of thousands of women and men have come out year after year to support the cause and for loved ones who have been personally affected by cancer. Their devotion and commitment to finding a cure is what has made the EIF Revlon Run/Walk so successful," says Ronald O. Perelman, chairman of Revlon, Inc., co-founder of the Run/Walk and co-founder of the Revlon/UCLA Women's Cancer Research Program. "Through significant advancement in education and research, so many women today are finding resources and treatments made available to them and with that aid they are beating the odds and surviving cancer."

Proceeds from past EIF Revlon Run/Walks have funded cutting-edge research, contributing to the development of the breakthrough gene treatment Herceptin(R) as well as other targeted therapies, bringing new and innovative treatment approaches to women's cancers worldwide. Monies raised have also helped numerous organizations in providing education, advocacy and outreach services to those affected by women's cancers.

"The heartfelt support that we receive each year for this event is overwhelming," says Lilly Tartikoff, co-founder of the EIF Revlon Run/Walk for Women and co-founder of the Revlon/UCLA Women's Cancer Research Program. "Every single person that participates helps to take us one step closer to a cure. Without our loyal supporters we would not be able to do this."

"We are truly grateful to the entertainment community for their invaluable support, helping us raise much-needed funds for crucial research and support programs to help the women we love," said Lisa Paulsen, president and CEO of the Entertainment Industry Foundation. "Step by step, all who participate in this even bring change and hope to women everywhere, like my cousin Dawn. She heard our message to get screened and went for her first mammogram at age 40 to learn she had early stage breast cancer. While this has been a challenging year for her, she's going to be okay."

2009 New York event beneficiaries include: Actors' Fund of America, Albert Einstein Cancer Center, CancerCare, Cancer Control Center of Harlem, Cancer Schmancer, Gilda's Club NYC, Gouverneur Healthcare Services, Memorial Sloan-Kettering Cancer Center, Nassau University Medical Center - The Breast Imaging Center, National Breast Cancer Coalition Fund, National Coalition for Cancer Survivorship, National Women's Cancer Research Alliance, Ovarian Cancer National Alliance, Saint Vincent Catholic Medical Centers of New York, William F. Ryan Community Health Center, and the YWCA of Brooklyn.

2009 Los Angeles event beneficiaries include: AltaMed Health Services Corporation, Asian American Network for Cancer Awareness, Research & Training, Cancer Schmancer, Citrus Valley Medical Center, Gilda Radner Ovarian Cancer Detection Program, John Wayne Cancer Institute, Los Angeles Breast Cancer Alliance, Providence Saint Joseph Foundation, Revlon/UCLA Women's Cancer Research Program, Team Survivor Los Angeles, UCLA Digital Mammography Program, USC/Norris Comprehensive Cancer Center and Hospital, Wellness Community, and Women of Color Breast Cancer Survivors' Support Project.

Sponsors for the 2009 EIF Revlon Run/Walk For Women include (combined) title sponsor Revlon(R); double platinum sponsors Macy's and Toyota; platinum sponsors ABC 7 and Northrop Grumman; gold sponsors Greater New York Hospital Association(TM), Aquafina(R), Cosi(R), HopStop(R) 95.5WPLJ; silver sponsors Bloomberg(TM), Lucille Roberts(TM), NBC-4(TM), People(TM) magazine, and T47 Telemundo(TM); Save the Tatas, The Zenith, Jamba Juice, Snak King, Wells Fargo, Yoplait and Larabar, bronze sponsor Kimo Kards(TM); and entertainment sponsors 20th Century Fox(TM), ABC(TM), CBS(TM), Fox(TM), NBC Universal(TM), Paramount(R), Sony Pictures(TM), The Walt Disney Company(TM), WB(TM), Panavision(R), Deluxe(R), IATSE(R), CAA, Endeavor, ICM(R), UTA and the William Morris Agency.


Registration for the Entertainment Industry Foundation Revlon Run/Walk For Women is $30 on or before April 6, 2009 and $35 after the deadline. For further information or to register, call 212.379.3199 (New York) or 310.322.3344 (Los Angeles) or visit

The Entertainment Industry Foundation (EIF), as a leading charitable organization of the entertainment industry, has distributed hundreds of millions of dollars to support charitable initiatives addressing critical health, education and social issues. Visit

Revlon is a worldwide cosmetics, hair color, beauty tools, fragrances, skincare, anti-perspirants/deodorants and personal care products company. The Company's vision is to provide glamour, excitement and innovation to consumers through high-quality products at affordable prices. Websites featuring current product and promotional information can be reached at, and Corporate and investor relations information can be accessed at The Company's brands, which are sold worldwide, include Revlon, Almay, Mitchum, Charlie, Gatineau and Ultima II.

SOURCE EIF Revlon Run/Walk
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Jessica Biel and Make The Difference Network Bring Holiday Cheer to Childrens Hospital Los Angeles
2. Jessica Simpson Lends Healthy Image for Drink Smart Campaign
3. Susan G. Komen for the Cure(R) Comments on Christina Applegates Breast Cancer Diagnosis
4. Internationally Known Psychic Christina Predicts Guides Others to Embrace a More Spiritual Way of Life
5. N. V. Perricone M.D. Cosmeceuticals Elevates Role of Christina Banas to Executive Director Global Communications
6. Crdentias VP of Marketing, Christina Hogan, Provides Exclusive Interview on Marketing Strategy
7. Medical Disposables Promotes Jennifer Munoz as Vice President of Marketing
8. Jennifer & Gigi: A Story of Love and Compassion with a Hollywood Twist -- In honor of National Family Caregivers Month, celebrates "Grandma Gene" and gives a voice to the community of caregivers around the world
9. Assurant Health Names Jennifer Kopps-Wagner Senior Vice President and General Counsel
10. Jennifer Samuels Joins GHG Grey Healthcare Group as Executive Vice President, Account Services
11. Host Jennifer Love Hewitt Joins SBE, The Abbey and Los Angeles Magazine for The Envelope Please, Benefiting AIDS Project Los Angeles
Post Your Comments:
(Date:2/22/2017)... ... February 22, 2017 , ... The National Academy of Certified ... the April 2017 testing period. NACCM, a nonprofit organization, has provided the premier ... exam is periodically re-calibrated to ensure that newly certified professionals are prepared to ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... understand each Medicare Advantage member’s risk, identify any gaps-in-coding, as well as ... helps transform the HCC Risk Adjustment process from a typical fragmented process ...
(Date:2/22/2017)... ... February 22, 2017 , ... Doctors on Liens is continuing its steady ... Steven H. Rauchman, practicing at North Valley Eye Medical Group in Mission Hills ... liability and other personal injury cases. These injuries have a major impact on ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... Using the ... leads utilizing a simple online checklist. Over a period of just 24 months, thousands ... assistance of an online checklist called T.A.D. , “The internet is not getting quieter. ...
(Date:2/22/2017)... ... February 22, 2017 , ... The Centers for ... help small practices in Delaware, New Jersey, Pennsylvania and West Virginia prepare for ... and CHIP Reauthorization Act of 2015 (MACRA). , This technical assistance, authorized ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... , February 23, 2017 ... market: the Berlin office was ... Magdalena Kritikos . The portfolio includes Entocort ® ... for the treatment of ulcerative colitis, and VistaPrep ® ... solutions, the Swiss specialty pharmaceutical company focused on the ...
(Date:2/23/2017)... 2017 MabVax Therapeutics Holdings, Inc ... company, announces that it has received notice from ... the initiation a Phase I clinical trial with ... MVT-1075 ( 177 Lu-CHX-A?-DTPA-HuMab5B1) is the Company,s novel ... initiate the phase I clinical trial in patients ...
(Date:2/23/2017)... 23, 2017 Provectus Biopharmaceuticals, Inc. (OTCQB: PVCT) ... oncology and dermatology biopharmaceutical company, today announced that it ... Rodrigues as special advisers to the Company,s Board ... the board on financial and corporate strategy. ... commitment of up to $2.5 million from Eric ...
Breaking Medicine Technology: